Brief: Oncorus Announces Research Collaboration With Daewoong Pharmaceutical
04/01/2023 12:15
Jan 4 (Reuters) - Daewoong Pharma 069620.KS :
* ONCORUS ANNOUNCES RESEARCH COLLABORATION WITH DAEWOONG
PHARMACEUTICAL FOR THE DEVELOPMENT OF LIPID NANOPARTICLE
FORMULATIONS FOR MRNA DRUG CANDIDATES
* ONCORUS -UNDER DEAL, CO & DAEWOONG TO CONDUCT JOINT
RESEARCH TO
IDENTIFY, EVALUATE FORMULATIONS OF DAEWOONG'S MRNAS ENCAPSULATED
IN CO'S PROPRIETARY LNPS
* ONCORUS INC - CO AND DAEWOONG HAVE AGREED TO COMMENCE
NEGOTIATIONS OF A POTENTIAL FUTURE LICENSE AND SUPPLY
ARRANGEMENT FOR FORMULATED PRODUCT
Source text for Eikon: ID:nGNX4ZlKW0
Further company coverage: 069620.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncorus
See all newsBrief: Oncorus Board Unanimously Approves Its Plan Of Dissolution, Liquidation
Brief: Oncorus Board Appoints Brian Shea As Interim CEO
U.S. STOCKS ON THE MOVE-Ford Motor, Theratechnologies, 3D Systems
Oncorus says no cash beyond Q3, cuts remaining jobs, shares tumble
Brief: Oncorus Announces Workforce Reduction Plan